Gambaran Umum
PreveCeutical Medical Inc., based in Canada, primarily operates within the healthcare sector, focusing on the development of innovative preventive therapies. The company leverages cutting-edge techniques in medicinal chemistry and biology to create products aimed at preventing ailments rather than merely treating symptoms. Key projects include the development of nature-identical cannabinoids and a peptide-based nasal spray designed to prevent the onset of COVID-19 and other respiratory viruses. This initiative reflects PreveCeutical's strategy of integrating both natural compounds and advanced scientific methods to innovate within the preventive medicine landscape, ultimately aiming to address significant unmet medical needs. Through such projects, PreveCeutical Medical Inc. seeks to establish a prominent role in the global healthcare market by advancing preventive medical solutions.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai operating income untuk PreveCeutical Medical Inc. per 2025 Jun 30 adalah -2.21 MM.
- Nilai net income untuk PreveCeutical Medical Inc. per 2025 Jun 30 adalah -2.60 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | -2.21 | -2.60 | |
2025-03-31 | -1.29 | -1.70 | |
2024-12-31 | -0.75 | -1.17 | |
2024-09-30 | -0.95 | -1.36 | |
2024-06-30 | -0.87 | -1.26 | |
2024-03-31 | -0.76 | -1.13 | |
2023-09-30 | -0.83 | -0.52 | |
2023-06-30 | -1.17 | -1.08 | |
2023-03-31 | -1.17 | -1.26 | |
2022-12-31 | -1.04 | -1.48 | |
2022-09-30 | -1.06 | -2.28 | |
2022-06-30 | -0.48 | -1.48 | |
2022-03-31 | -0.64 | -1.83 | |
2021-12-31 | -0.83 | -1.73 | |
2021-09-30 | -2.09 | -2.90 | |
2021-06-30 | -1.75 | -2.45 | |
2021-03-31 | -2.17 | -3.78 | |
2020-12-31 | -2.09 | -3.80 | |
2020-09-30 | 0.00 | -0.73 | -2.23 |
2020-06-30 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | -0.00 | -0.00 |
2024-06-30 | -0.00 | -0.00 |
2024-03-31 | ||
2023-09-30 | -0.00 | -0.00 |
2023-06-30 | -0.00 | -0.00 |
2023-03-31 | -0.00 | -0.00 |
2022-12-31 | -0.00 | |
2022-09-30 | -0.00 | -0.00 |
2022-06-30 | -0.00 | -0.00 |
2022-03-31 | -0.00 | -0.00 |
2021-12-31 | -0.00 | |
2021-09-30 | -0.01 | -0.01 |
2021-06-30 | -0.00 | -0.00 |
2021-03-31 | -0.01 | -0.01 |
2020-12-31 | -0.01 | -0.01 |
2020-09-30 | -0.01 | -0.01 |
2020-06-30 | -0.01 | -0.01 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk PreveCeutical Medical Inc. per 2025 Jun 30 adalah -0.84 MM.
- Nilai cash from investing activities untuk PreveCeutical Medical Inc. per 2025 Jun 30 adalah -0.06 MM.
- Nilai kas dari aktivitas pendanaan untuk PreveCeutical Medical Inc. per 2025 Jun 30 adalah 0.91 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -0.84 | -0.06 | 0.91 |
2025-03-31 | -0.47 | -0.06 | 0.54 |
2024-12-31 | -0.43 | -0.00 | 0.49 |
2024-09-30 | -0.40 | -0.00 | 0.40 |
2024-06-30 | -0.33 | -0.00 | 0.34 |
2024-03-31 | -0.26 | 0.00 | 0.25 |
2023-09-30 | -0.03 | 0.00 | 0.35 |
2023-06-30 | -0.03 | 0.00 | 0.35 |
2023-03-31 | -0.08 | -0.00 | 0.24 |
2022-12-31 | -0.22 | 0.00 | 0.21 |
2022-09-30 | -0.45 | -0.05 | 0.12 |
2022-06-30 | -0.17 | -0.05 | 0.09 |
2022-03-31 | -0.69 | -0.05 | 0.10 |
2021-12-31 | -0.43 | -0.05 | 0.14 |
2021-09-30 | -0.55 | 0.02 | 0.18 |
2021-06-30 | -0.26 | -0.00 | 0.32 |
2021-03-31 | 0.18 | -0.00 | 0.33 |
2020-12-31 | 0.06 | -0.00 | 0.18 |
2020-09-30 | 0.29 | -0.02 | 0.03 |
2020-06-30 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 | |||
2020-06-30 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | ||
2024-06-30 | ||
2024-03-31 | ||
2023-09-30 | ||
2023-06-30 | ||
2023-03-31 | ||
2022-12-31 | ||
2022-09-30 | ||
2022-06-30 | ||
2022-03-31 | ||
2021-12-31 | ||
2021-09-30 | ||
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 | ||
2020-09-30 | ||
2020-06-30 |
Efektivitas Manajemen
- roa untuk PreveCeutical Medical Inc. pada 2025 Jun 30 adalah -9.60.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -9.60 | ||||
2025-03-31 | -6.48 | ||||
2024-12-31 | -6.48 | ||||
2024-09-30 | -6.02 | ||||
2024-06-30 | -3.10 | ||||
2024-03-31 | -2.74 | ||||
2023-09-30 | -7.68 | ||||
2023-06-30 | -10.58 | ||||
2023-03-31 | -14.85 | ||||
2022-12-31 | -9.27 | ||||
2022-09-30 | -6.03 | ||||
2022-06-30 | -16.35 | ||||
2022-03-31 | -13.06 | ||||
2021-12-31 | -9.59 | ||||
2021-09-30 | -5.36 | ||||
2021-06-30 | -7.34 | ||||
2021-03-31 | -5.70 | ||||
2020-12-31 | -4.43 | ||||
2020-09-30 | -1.64 | -7.70 | 0.69 | 0.99 | |
2020-06-30 | -1.88 |
Gross Margins
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 | |||
2020-06-30 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) |